Navigation Links
Brooks(R) Sports Launches BioMoGo Biodegradable Shoe
Date:7/24/2008

Ground-breaking Technology Debuts in the Trance(TM) 8 Performance Running

Shoe

BOTHELL, Wash., July 24 /PRNewswire/ -- Leading performance running company Brooks Sports, Inc. today announced that BioMoGo, the world's first biodegradable midsole, is now available to consumers in the new Trance(TM) 8 premium support shoe. Brooks designed BioMoGo to biodegrade 50 times faster than conventional athletic shoe midsoles, making it one of the most significant sustainable technologies to hit the running footwear market.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080724/AQTH512)

BioMoGo midsoles include a non-toxic, natural additive that exponentially increases the rate of biodegradation by encouraging anaerobic microbes to break down nutrients into reusable byproducts. While traditional Ethylene Vinyl Acetate(TM) (EVA) midsoles can last up to 1,000 years in an enclosed landfill, extensive tests have proven that BioMoGo can biodegrade in roughly 20 years when placed in the same environment. By using BioMoGo in its shoes, Brooks will save nearly 30 million pounds of landfill waste over a 20-year period.

Although the application of BioMoGo technology to footwear involves valuable intellectual property, Brooks decided at the outset that it would treat its new midsole discovery as an "open source" innovation and share it with other footwear manufacturers and interested industries.

"Environmental stewardship is an important business pillar for Brooks, and we're committed to creating products that help preserve and, whenever possible, enhance the environment," said Jim Weber, president and CEO of Brooks. "Sharing BioMoGo presents a chance for greater environmental impact beyond Brooks and supports the spirit with which it was created."

Without losing durability or performance, BioMoGo will begin to break down only wh
'/>"/>

SOURCE Brooks Sports, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Complimentary Sports Injury Prevention Pamphlet for Women Offered by NOHC of Chicago
2. Sports Luminaries Andre Agassi, Jerry Rice, Scottie Pippen, Helio Castrovenes, Richard Goose Gossage Among Those Named 2008 Great Sports Legends
3. Legendary Sports Icons, Nadia Comaneci and Mark Spitz, Support Your Personal Best Public Education Campaign
4. Paolo Aglietti, MD, President of the International Society of Knee Surgery and Arthroscopy, Inducted into Sports Medicine Hall of Fame
5. Playing It Safe With High School Sports
6. Renowned Iowa Orthopaedic Surgeon, John Albright, MD, Inducted into Sports Medicine Hall of Fame
7. Reknowned Orthopaedic Surgeon to be Installed as President of Sports Medicine Society
8. Pioneering Solutions To Fight Staph, MRSA Infections in Sports Facilities and Synthetic Turf Fields
9. Sports Dopings Effect May Be in the Mind
10. Indiana University research at the American College of Sports Medicine annual conference
11. Zero-calorie Aqua-Lyte hydrates as well as leading sports drink

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... Biotech firm Replikins L...f the H1N1 virus genomic data. It shows that the ...f 3.7 (s.d. 4.5) during the virus,s current outbre...evels this week of 2.0 (s.d. 0.1). The H1N1 infect... Boston (PRWEB) November 27, 2009...
(Date:11/27/2009)..., , SAN FRANCISCO, Nov. 27 /PRNewswire-Firs...) announced that Blair Lambert, CFO/COO, will pres... will be held at the May Fair Hotel in London, Eng.... GMT. ,, To listen to a live broadcast of The ...net, please log on to www.gymboree.com, click on "...
(Date:11/27/2009)..., , NEUILLY-SUR-SEINE, France, Nov. 27 /...merican professional cycling team dedicated to eth...f cycling champions, announced today that it will ...f Transitions Optical as a new sponsor of the team...acturer of adaptive eyewear, offering the most adv...
(Date:11/27/2009)... XenaCare Holdings has an...he Arthritis Foundation, one of the largest nonpro...and public health education. , ...- XenaCare Holdings, Inc. (OTCBB: XCHO), a company...tion of consumer healthcare products, has announce...
(Date:11/27/2009)...Soaring rates to bring unprecedented medical, econ... Nov. 27 (HealthDay News) -- The number of people ...double over the next 25 years, a new study predict...t 44.1 million people with the disease, up from 23... of treating people with diabetes will triple, the...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3
... Privatizing water supplies is only a pretext for ...precious resources of the people at large, activis...orldwide in the bottled water market, corporations...ontrols one-third of the U.S. market and sells 70 ...
... A revolutionary new imaging technology is expecte...s. Elasticity imaging is an ultrasound technique r... measure the stiffness of tissue, relative to surr...psies turn up positive for cancer. In a re...
... Loading a Super Soaker (a brand of recreational ...ight, worse ejaculating on stuffed animals, how de... are heard these days after a popular 17-year-old .... A week or so later, Mayor Tish Colombi and ...
... New tuberculosis (TB) vaccines in development hav...strains of TB, including multidrug-resistant (MDR)...rald C. Sadoff, president and CEO of the Aeras Glo... solely to creating new TB vaccines, is working to...
... Additional beneficial effects on cardiometabolic ...s in trials of the anti-obesity drug rimonabant ma...e in the June issue of Drug and Therapeutics Bulle...n cardiometabolic risk factors are beyond those ex...
... Tobacco is perhaps the most common addiction all .... Alarmed by the devastating impact of tob...ld Health Organization is calling for stringent re...1 crore, according to WHO estimates. The ...
Other Medicine News:Health News:Multinationals Exploit Groundwater Sources, and People Suffer 2Health News:Multinationals Exploit Groundwater Sources, and People Suffer 3Health News:Multinationals Exploit Groundwater Sources, and People Suffer 4Health News:Multinationals Exploit Groundwater Sources, and People Suffer 5Health News:Beer Bashes of Teens Spinning Out of Control in US 2Health News:New TB Vaccines in Could Protect Against All Drug Resistant Strains 2Health News:New TB Vaccines in Could Protect Against All Drug Resistant Strains 3Health News:Anti-obesity Drugs Claimed Additional Benefits on cardiometabolic Risk Factors Questioned 2Health News:Tobacco Menace and What can Be Done About It 2Health News:Tobacco Menace and What can Be Done About It 3Health News:Tobacco Menace and What can Be Done About It 4
(Date:11/25/2009)...v. 25 Praxis Electronic Medical Re...n Academy of Family Physicians, (AAFP) Family Prac...urvey for improving medical quality, health mainte...w ARRA Stimulus legislation. Praxis also ranked #1... effect in determining their salary. Finally, Prax...
(Date:11/25/2009)... Pharmasset, Inc. (Nasda...y committed to discovering, developing and commerc...ported financial results for the fiscal year ended...set held $58.4 million in cash, cash equivalents a... and 2009 Highlights ,, RG7128 ,, Phase...
(Date:11/25/2009)... The FDA granted traditional appro...n-nucleoside reverse transcriptase inhibitor (NNRT...ated for use in treatment-experienced adults who a...ns resistant to an NNRTI and other antiretroviral ...n 48-week data from two Phase 3 studies known as D...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Measuring intellectual disability 8977 1Measuring intellectual disability 8977 2M2SYS Technology to Offer Desktop Biometric Technology to Kronos Customers 8975 1M2SYS Technology to Offer Desktop Biometric Technology to Kronos Customers 8975 2BD Announces CE Marking of BD ProbeTec 26amp 3B 238482 3B Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae 49844 1BD Announces CE Marking of BD ProbeTec 26amp 3B 238482 3B Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae 49844 2BD Announces CE Marking of BD ProbeTec 26amp 3B 238482 3B Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae 49844 3BD Announces CE Marking of BD ProbeTec 26amp 3B 238482 3B Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae 49844 4
...IEW, Calif., June 22, 2007 /PRNewswire/ -- MAP,Pha...esent Phase 2,data from its Unit Dose Budesonide (...the World Asthma Meeting at the Lutfi Kirdar,Conve... The oral and poster presentation entitled, "Effic...lation of budesonide for,nebulized delivery in a 6...
... Announces Bioinformatics Partnership with,Illumin...une 21, 2007,-GenoLogics, a leading developer of l... sciences research, today announced that,it has pe...technology partner and participant in IlluminaConn... by Illumina to advance,data integration and analy...
Other Medicine Technology:MAP Pharmaceuticals to Present Unit Dose Budesonide Phase 2,Clinical Data at the World Asthma Meeting 2GenoLogics Announces Bioinformatics Partnership with Illumina 2GenoLogics Announces Bioinformatics Partnership with Illumina 3
Shahinian Lacrimal Cannula
Solo-Care Multipurpose Solution
Graether Collar Button On Handle
Graether Irrigating Collar Button
Medicine Products: